Seropositivity was strongly associated with ILD risk in this large prospective cohort study.
What’s new in Sjögren syndrome: (1) clinical clues herald progression to a life-threatening variant and (2) a common therapy exacerbates comorbidities.
British researchers quantified the burden of continuing weight gain on the risk of PsA.
Recent studies explore the vascular underpinnings of neuropsychiatric damage as well as the risk of resistant hypertension in patients with SLE.
Be alert for the development of uveitis in older patients with gout, especially those who have multiple comorbidities.
Five questions to test your knowledge of the prevalence, risk, and classification of RA.
Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis Gets FDA Nod
The approval is based on data from two randomized, sham injection-controlled, double-masked phase 3 clinical trials with patient follow-up for 3 years.
Concerns have been raised in the past about the possibility of infection caused by immune suppression.
Be vigilant for diffuse idiopathic skeletal hyperostosis in patients who have ankylosing spondylitis, since they may be less clearly symptomatic.
Here: highlights of some of the studies that will be presented at the American College of Rheumatology 2018 Annual Meeting in Chicago from October 19 to 24.